Protein Sciences, UNIGEN to source Flublok Influenza Vaccine from Japan
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 16 Feb, 2016
Tokyo: North American pharmaceutical companies Protein Sciences Corporation and UMN Pharma Inc. have announced that Prot...Read more
Teva recalls amikacin sulfate injection
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2016
Singapore: Teva Pharmaceuticals has announced a voluntary recall of one lot of amikacin sulfate injection USP, 1 gram/4m...Read more
ABIVAX to market typhoid, meningococcus vaccines in Asia
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 18 Nov, 2014
Singapore: ABIVAX, Europe-based clinical stage biopharmaceutical company developing and commercializing anti-viral compo...Read more
Global respiratory syncytial virus treatment market to touch $2.3 bn by 2024
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 14 Jan, 2016
Singapore: The global Respiratory Syncytial Virus (RSV) treatment market will expand to unprecedented levels over the ne...Read more
Bill & Melinda Gates Foundation supports Takeda with $38 m to eradicate polio
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 10 May, 2016
Japan's Takeda Pharmaceutical Company Limited has announced a partnership with the Bill & Melinda Gates Foundation t...Read more
Merck gets FDA nod for Bridion
Vaccines | Regulatory | By BioSpectrum Bureau | 0 Comment | 22 Dec, 2015
Singapore: Merck (MSD) has recieved US Food and Drug Administration (FDA) approval for Bridion (sugammadex) Injection 10...Read more
BioDiem gets hepatitis vaccine tech from Canberra univ
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 29 Jun, 2012
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement to lice...Read more
Infect mosquitoes with Wolbachia, stop diseases
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 11 Apr, 2013
Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected wi...Read more
Takeda close to releasing Norovirus vaccine
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013
Singapore: Japan's drug major Takeda Pharmaceutical has said that they are set to finish the early stage human studies o...Read more
China to set up a new vaccine tracking system
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 27 Apr, 2016
Singapore: According to a recent decision publicized by the Chinese government, wholesalers will no longer be allowed to...Read more
Yisheng BioPharma gets positive result in rabies vaccine trial
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 04 Jan, 2016
Singapore: Yisheng Biopharma, China based biopharmaceutical company, has recieved positive topline results from Phase I ...Read more
China's Hualan Bio gets WHO nod for influenza vaccine
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2015
Singapore: China based Hualan Bio has recieved world health organization (WHO) pre-qualification approval for influenza ...Read more
Teikoku Pharma gets USFDA nod for non-alcohol docetaxel injection
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 04 Jan, 2016
Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the tre...Read more
German firm proceeds on ebola vaccine trial
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2015
Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the cli...Read more
Merck's Ebola vaccine found promising in clinical trials
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 03 Aug, 2015
Singapore: In a recent interim study published in the Lancet medical journal, Merck's Ebola vaccine was found to be "hig...Read more
Teva recalls Adrucil injection for potential foriegn particle presence
Vaccines | Regulatory | By BioSpectrum Bureau | 3 Comment | 28 Jul, 2015
Singapore: Teva Parenteral Medicines has recalled six lots of Adrucil (fluorouracil injection) due to the potential pres...Read more
Drug resistance keeps malaria threat alive in India
Vaccines | Analysis | By Rahul Koul Koul | 2 Comment | 02 Jul, 2012
The current anti-malarial market in India is approximately $80 million (Rs 450 crore) with an annual growth rate of 17 p...Read more
New vaccine against Hepatatis B developed by Cuba
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 17 Aug, 2015
Singapore: Researchers from Cuba have developed a new vaccine for treatment of chronic hepatitis B. The vaccine HeberNas...Read more